SNTI Senti Biosciences Holdings, Inc.

Fundamentals / CIK 0001854270 / USD

Senti Biosciences Holdings, Inc. reported $74K in revenue and a net loss of $43.02M for the trailing twelve months ended September 30, 2026, with a -67652.7% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SNTI in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2021 to 2025), reported in USD.

$11.73M$5.86M$0-$66.80MFY 2021 Revenue: $2.76MFY 2021 Net Income: -$55.32M2021FY 2022 Revenue: $4.29MFY 2022 Net Income: -$58.21M2022FY 2023 Revenue: $2.56MFY 2023 Net Income: -$71.06M2023FY 2024 Revenue: $0FY 2024 Net Income: -$52.79M2024FY 2025 Revenue: $22KFY 2025 Net Income: -$61.44M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $22K $0 $2.56M $4.29M $2.76M
Research & Development $37.59M $34.36M $32.15M $28.14M $21.96M
Total Operating Expenses $68.80M $61.04M $95.29M $66.37M $43.21M
Operating Income -$68.78M -$61.04M -$92.73M -$62.08M -$40.45M
EBITDA -$65.14M -$57.20M -$89.17M -$60.68M -$39.68M
Income Tax Expense $0 $0 -- -- --
Net Income -$61.44M -$52.79M -$71.06M -$58.21M -$55.32M
Basic EPS -$2.73 -$12.03 -$16.01 -$22.30 -$190.00
Diluted EPS -$2.73 -$12.03 -$16.01 -$22.30 -$190.00
Basic Shares Outstanding 22.5M 4.6M 4.4M 2.6M 291.2K
Diluted Shares Outstanding 22.5M 4.6M 4.4M 2.6M 291.2K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $19K $17K $16K $22K $0 $0 $0 $0
Research & Development $6.07M $7.77M $5.28M $7.76M $10.52M $10.03M $9.28M $7.77M
Total Operating Expenses $12.34M $14.51M $4.63M $18.66M $16.95M $16.80M $16.40M $16.17M
Operating Income -$12.32M -$14.49M -$4.62M -$18.64M -$16.95M -$16.80M -$16.40M -$16.17M
EBITDA -$11.67M -$13.82M -$3.93M -$17.74M -$16.04M -$15.88M -$15.47M -$15.23M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$11.59M -$12.75M -$4.22M -$14.47M -$18.13M -$14.73M -$14.11M -$610K
Basic EPS -$0.37 -$0.41 -$0.14 -- -$0.69 -$0.56 -$1.41 --
Diluted EPS -$0.37 -$0.41 -$0.14 -- -$0.69 -$0.56 -$1.41 --
Basic Shares Outstanding 31.1M 31.1M 31.0M -- 26.2M 26.1M 10.0M --
Diluted Shares Outstanding 31.1M 31.1M 31.0M -- 26.2M 26.1M 10.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $16.42M $48.28M $35.93M $57.62M $56.03M
Short-Term Investments -- -- $0 $40.94M $0
Cash & Short-Term Investments $16.42M $48.28M $35.90M $98.60M $56.00M
Accounts Receivable, Net -- -- -- $626K $483K
Other Current Assets $0 $584K $195K $101K $275K
Total Current Assets $23.27M $58.96M $71.20M $102.6M $60.19M
Property, Plant & Equipment, Net $12.89M $21.29M $25.34M $51.36M $12.37M
Other Non-Current Assets $19K $105K $215K $283K $176K
Total Non-Current Assets $27.95M $38.88M $48.28M $78.21M $36.51M
Total Assets $51.22M $97.84M $119.5M $180.8M $96.70M
Accounts Payable $2.94M $1.45M $1.25M $1.37M $5.19M
Deferred Revenue (Current) $43K $0 $0 $799K $1.66M
Total Current Liabilities $13.97M $13.15M $12.67M $18.05M $14.54M
Deferred Revenue (Non-Current) -- -- -- $0 $176K
Other Non-Current Liabilities $8.10M $5.05M $0 -- --
Total Non-Current Liabilities $31.66M $33.94M $39.90M $35.48M $21.78M
Total Liabilities $45.63M $47.09M $52.57M $53.53M $36.33M
Total Debt (incl. Leases) $28.89M $33.64M $37.67M $37.09M $22.73M
Common Stock $3.0K $1.0K $1.0K $4.0K $0
Retained Earnings -$358.6M -$297.1M -$244.3M -$173.3M -$115.1M
Accumulated Other Comp. Income -- -- $0 $1.0K $0
Total Stockholders' Equity $5.59M $25.65M $66.91M $127.3M -$111.5M
Total Equity $5.59M $25.65M $66.91M $127.3M -$111.5M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $5.55M $6.46M $8.94M $16.42M $12.24M $21.58M $33.80M $48.28M
Cash & Short-Term Investments $5.55M $6.46M $8.94M $16.42M $12.24M $21.58M $33.80M $48.28M
Other Current Assets $1.0K $288K -- $0 $0 $0 $0 $584K
Total Current Assets $9.52M $13.01M $14.79M $23.27M $18.16M $32.52M $45.21M $58.96M
Property, Plant & Equipment, Net $10.77M $11.43M $12.10M $12.89M $18.69M $19.59M $20.53M $21.29M
Other Non-Current Assets $0 $0 $5.0K $19K $34K $52K $76K $105K
Total Non-Current Assets $18.84M $20.10M $23.45M $27.95M $34.53M $36.02M $37.56M $38.88M
Total Assets $28.36M $33.10M $38.24M $51.22M $52.69M $68.54M $82.78M $97.84M
Accounts Payable $2.40M $2.25M $1.05M $2.94M $1.77M $1.02M $1.56M $1.45M
Deferred Revenue (Current) $60K $11K $27K $43K -- -- -- $0
Total Current Liabilities $17.59M $15.77M $14.27M $13.97M $12.03M $9.99M $10.73M $13.15M
Other Non-Current Liabilities $8.00M $8.00M $8.16M $8.10M $7.57M $7.57M $6.56M $5.05M
Total Non-Current Liabilities $20.37M $20.74M $21.41M $31.66M $32.54M $33.90M $34.19M $33.94M
Total Liabilities $37.96M $36.51M $35.68M $45.63M $44.56M $43.89M $44.92M $47.09M
Total Debt (incl. Leases) $15.27M $16.23M $19.14M $28.89M $30.12M $31.31M $32.45M $33.64M
Common Stock $3.0K $3.0K $3.0K $3.0K $3.0K $3.0K $3.0K $1.0K
Retained Earnings -$387.1M -$3.40M -$362.8M -$358.6M -$344.1M -$326.0M -$311.2M -$297.1M
Total Stockholders' Equity -$9.60M -$3.40M $2.56M $5.59M $8.12M $24.65M $37.86M $25.65M
Total Equity -$9.60M -$3.40M $2.56M $5.59M $8.12M $24.65M $37.86M $25.65M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$61.44M -$52.79M -$71.06M -$58.21M -$55.32M
Depreciation & Amortization $3.64M $3.84M $3.56M $1.40M $769K
Stock-Based Compensation $5.71M $1.75M $9.67M $16.39M $2.29M
Change in Receivables -- -- -- -$131K -$395K
Change in Payables $1.74M $797K -$290K $186K -$617K
Operating Cash Flow -$43.44M -$41.40M -$52.40M -$34.90M -$34.63M
Capital Expenditure -$196K -$26K -$12.04M -$41.37M -$5.54M
Free Cash Flow -$43.64M -$41.42M -$64.43M -$76.27M -$40.18M
Investing Cash Flow -$184K $34K $30.08M -$81.96M -$5.54M
Common Stock Issued -- $1.81M $512K $728K $0
Financing Cash Flow $11.76M $53.73M $779K $118.6M $68.44M
Net Change in Cash -$31.87M $12.37M -$21.54M $1.70M $28.26M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$11.59M -$12.75M -$4.22M -$14.47M -$18.13M -$14.73M -$14.11M -$610K
Depreciation & Amortization $650K $667K $688K $893K $904K $914K $926K $937K
Stock-Based Compensation $961K $1.05M $1.31M $1.43M $1.55M $1.53M $1.20M $605K
Change in Payables $156K $1.22M -$1.89M $1.17M $750K -$537K $357K $1.24M
Operating Cash Flow -$6.73M -$14.25M -$7.48M -$6.88M -$9.45M -$13.07M -$14.05M -$13.50M
Capital Expenditure -- -- -- $0 $0 -$196K $0 -$11K
Free Cash Flow -- -- -- -$6.88M -$9.45M -$13.27M -$14.05M -$13.52M
Investing Cash Flow $0 $0 $114K $0 $0 -$184K $0 -$11K
Financing Cash Flow $5.82M $9.68M -$118K $11.04M $124K $1.01M -$414K $51.29M
Net Change in Cash -$907K -$4.57M -$7.49M $4.17M -$9.32M -$12.25M -$14.46M $37.77M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -312631.8% -- -3620.7% -1448.5% -1464.9%
Net Profit Margin -279263.6% -- -2774.6% -1358.1% -2003.6%
Return on Equity (ROE) -1099.3% -205.8% -106.2% -45.7% --
Return on Assets (ROA) -119.9% -54.0% -59.5% -32.2% -57.2%
Current Ratio 1.67x 4.49x 5.62x 5.68x 4.14x
Quick Ratio 1.18x 3.67x 2.83x 5.50x 3.88x
Debt to Equity 5.17x 1.31x 0.56x 0.29x --
Revenue Growth (YoY) -- -100.0% -40.2% +55.2% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -67652.7% -99434.5% -149994.7% -312631.8% -- -- -- --
Net Profit Margin -58140.5% -90116.4% -135650.0% -279263.6% -- -- -- --
Return on Equity (ROE) -- -- -2009.6% -1099.3% -585.9% -236.6% -144.7% -205.8%
Return on Assets (ROA) -151.7% -149.7% -134.8% -119.9% -90.3% -85.1% -66.2% -54.0%
Current Ratio 0.54x 0.83x 1.04x 1.67x 1.51x 3.26x 4.22x 4.49x
Quick Ratio 0.32x 0.41x 0.63x 1.18x 1.02x 2.16x 3.15x 3.67x
Debt to Equity -- -- 7.46x 5.17x 3.71x 1.27x 0.86x 1.31x
Source: SEC EDGAR CompanyFacts (CIK 0001854270) · from March 31, 2021 Data through September 30, 2026 · synced Nov 21, 2026, 05:09 UTC · Open in terminal